These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17194818)

  • 1. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia.
    Mendez MF; Shapira JS; McMurtray A; Licht E
    Am J Geriatr Psychiatry; 2007 Jan; 15(1):84-7. PubMed ID: 17194818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
    Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
    Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation syndrome following donepezil cessation.
    Singh S; Dudley C
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):282-4. PubMed ID: 12673601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study.
    Mori S; Mori E; Iseki E; Kosaka K
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):190-5. PubMed ID: 16594943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.
    Ishikawa K; Motoi Y; Mizuno Y; Kubo S; Hattori N
    Psychogeriatrics; 2014 Jun; 14(2):93-100. PubMed ID: 24661498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil-induced confusional state in a patient with autopsy-proven behavioral-variant frontotemporal dementia.
    Arciniegas DB; Anderson CA
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E25-6. PubMed ID: 24026732
    [No Abstract]   [Full Text] [Related]  

  • 8. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease.
    Marinho V; Laks J; Engelhardt E; Conn D
    J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.
    Fagerlund B; Søholm B; Fink-Jensen A; Lublin H; Glenthøj BY
    Clin Neuropharmacol; 2007; 30(1):3-12. PubMed ID: 17272964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galantamine in frontotemporal dementia and primary progressive aphasia.
    Kertesz A; Morlog D; Light M; Blair M; Davidson W; Jesso S; Brashear R
    Dement Geriatr Cogn Disord; 2008; 25(2):178-85. PubMed ID: 18196898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of risperidone and donepezil in Lewy body dementia.
    Geizer M; Ancill RJ
    Can J Psychiatry; 1998 May; 43(4):421-2. PubMed ID: 9598283
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
    Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
    Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic improvement in Down syndrome-associated cognitive impairment with donepezil.
    Kondoh T; Amamoto N; Doi T; Hamada H; Ogawa Y; Nakashima M; Sasaki H; Aikawa K; Tanaka T; Aoki M; Harada J; Moriuchi H
    Ann Pharmacother; 2005 Mar; 39(3):563-6. PubMed ID: 15701776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia.
    Marczinski CA; Davidson W; Kertesz A
    Cogn Behav Neurol; 2004 Dec; 17(4):185-90. PubMed ID: 15622012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
    Alwahhabi FK
    J Psychopharmacol; 2005 Mar; 19(2):214-6. PubMed ID: 15728444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual cardiovascular adverse effect of donepezil.
    Celik IE; Acar B; Çay S
    Intern Med J; 2015 Aug; 45(8):877-8. PubMed ID: 26220031
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.